Logo image of SNDX

SYNDAX PHARMACEUTICALS INC (SNDX) Stock Analyst Earnings Estimates

NASDAQ:SNDX - Nasdaq - US87164F1057 - Common Stock - Currency: USD

9.98  +0.06 (+0.6%)

After market: 10.27 +0.29 (+2.91%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
SNDX revenue by date.SNDX revenue by date.

-100.00%
23.68M126.61M
434.67%
264.14M
108.62%
358.9M
35.87%
543.58M
51.46%
649.61M
19.51%
882.48M
35.85%
1.091B
23.63%
1.146B
5.04%
EBITDA
YoY % growth
SNDX ebitda by date.SNDX ebitda by date.
-151.77M
-678.39%
-229.942M
-51.51%
-339.664M
-47.72%
-353.033M
-3.94%
-189.836M
46.23%
-7.732M
95.93%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
SNDX ebit by date.SNDX ebit by date.
-151.8M
-679.39%
-229.954M
-51.48%
-339.672M
-47.71%
-344.573M
-1.44%
-242.006M
29.77%
-147.636M
38.99%
-7.65M
94.82%
71.171M
1,030.34%
240.62M
238.09%
430.39M
78.87%
469.51M
9.09%
Operating Margin
SNDX operating margin by date.SNDX operating margin by date.
N/AN/A-1,434.43%-272.15%-91.62%-41.14%-1.41%10.96%27.27%39.45%40.97%
EPS
YoY % growth
SNDX eps by date.SNDX eps by date.
-2.45
-669.77%
-2.96
-20.82%
-3.73
-26.01%
-3.94
-5.60%
-2.73
30.62%
-1.81
33.93%
-0.59
67.42%
0.60
202.31%
2.32
285.88%
3.93
69.32%
4.16
5.84%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-1.03
-28.28%
-0.95
2.61%
-0.91
17.36%
-0.90
8.41%
-0.79
23.47%
-0.63
33.74%
-0.42
53.99%
Revenue
Q2Q % growth
27.753M
692.94%
34.118M
172.94%
42.969M
459.49%
48.297M
140.98%
52.02M
87.44%
68.34M
100.30%
89.76M
108.89%
EBITDA
Q2Q % growth
-88.895M
-19.79%
-86.264M
3.69%
-88.859M
7.78%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-89.472M
-20.56%
-84.996M
5.11%
-82.573M
14.31%
-70.544M
15.53%
-69.36M
22.48%
-56.1M
34.00%
-37.74M
54.29%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
-0.98
-15.29%
-1.360.3827.80%
Q4 2024
Q2Q % growth
-1.10
-10.00%
-0.23-0.87-370.62%
Q3 2024
Q2Q % growth
-0.98
-34.25%
-1.140.1613.67%
Q2 2024
Q2Q % growth
-0.80
-25.00%
-0.930.1314.20%
Q1 2024
Q2Q % growth
-0.85
-44.07%
-1.000.1514.84%
Q4 2023
Q2Q % growth
-1.00
-61.29%
-1.010.011.39%
Q3 2023
Q2Q % growth
-0.73
-25.86%
-0.810.0810.03%
Q2 2023
Q2Q % growth
-0.64
-3.23%
-0.750.1114.31%
Q1 2023
Q2Q % growth
-0.59
6.35%
-0.610.022.90%
Q4 2022
Q2Q % growth
-0.62
-134.25%
-0.660.046.31%
Q3 2022
Q2Q % growth
-0.58
-45.00%
-0.650.0710.45%
Q2 2022
Q2Q % growth
-0.62
-40.91%
-0.650.034.53%
Q1 2022
Q2Q % growth
-0.63
-16.67%
-0.650.022.73%
Q4 2021
Q2Q % growth
1.81
511.36%
0.281.53537.56%
Q3 2021
Q2Q % growth
-0.40
13.04%
-0.24-0.16-69.27%
Q2 2021
Q2Q % growth
-0.44
-4.76%
-0.730.2939.67%
Q1 2021
Q2Q % growth
-0.54
3.57%
-0.660.1218.34%
Q4 2020
Q2Q % growth
-0.44 -0.500.0611.33%
Q3 2020
Q2Q % growth
-0.46
-12.20%
-0.45-0.01-3.12%
Q2 2020
Q2Q % growth
-0.42
10.64%
-0.450.037.64%
Q1 2020
Q2Q % growth
-0.56
-5.66%
-0.52-0.04-6.99%
Q4 2019
Q2Q % growth
-0.44 -0.43-0.01-1.43%
Q3 2019
Q2Q % growth
-0.41 -0.480.0714.61%
Q2 2019
Q2Q % growth
-0.47 -0.44-0.03-7.53%
Q1 2019
Q2Q % growth
-0.53 -0.570.046.40%
SNDX Yearly EPS VS EstimatesSNDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 -4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
20.042M 14.722M5.32M36.14%
Q4 2024
Q2Q % growth
7.68M 87.63M-79.95M-91.24%
Q3 2024
Q2Q % growth
12.5M 11.423M1.077M9.43%
Q1 2023
Q2Q % growth
437.141K-437.141K-100.00%
Q4 2022
Q2Q % growth

-100.00%
382.5K-382.5K-100.00%
Q3 2022
Q2Q % growth

-100.00%
765K-765K-100.00%
Q2 2022
Q2Q % growth

-100.00%
1.403M-1.403M-100.00%
Q1 2022
Q2Q % growth

-100.00%
2.173M-2.173M-100.00%
Q4 2021
Q2Q % growth
126.6M
31,550.00%
59.854M66.746M111.51%
Q3 2021
Q2Q % growth
12.4M
3,000.00%
29.937M-17.537M-58.58%
Q2 2021
Q2Q % growth
400K 183.6K216.4K117.86%
Q1 2021
Q2Q % growth
400K 229.5K170.5K74.29%
Q4 2020
Q2Q % growth
400K 204K196K96.08%
Q3 2020
Q2Q % growth
400K 306K94K30.72%
Q2 2020
Q2Q % growth
400K 408K-8K-1.96%
Q1 2020
Q2Q % growth
400K 860.033K-460.033K-53.49%
Q4 2019
Q2Q % growth
400K 379.032K20.968K5.53%
Q3 2019
Q2Q % growth
400K 379.032K20.968K5.53%
Q2 2019
Q2Q % growth
400K 383.857K16.143K4.21%
Q1 2019
Q2Q % growth
400K 371.79K28.21K7.59%
SNDX Yearly Revenue VS EstimatesSNDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.58% -1.52% -1.25% -0.03%
Revenue1.6% 38.32% 1.5% 47.11%